5-Fluorouracil treatment induces characteristic T>G mutations in human cancer

5-Fluorouracil (5-FU) is a commonly used chemo drug to treat cancer patients. Using in vitro 5-FU treated organoids and in vivo 5-FU treated human cancer data, the authors describe a 5-FU mutational signature that is similar to COSMIC signature 17 frequently observed in untreated cancers

Guardado en:
Detalles Bibliográficos
Autores principales: Sharon Christensen, Bastiaan Van der Roest, Nicolle Besselink, Roel Janssen, Sander Boymans, John W. M. Martens, Marie-Laure Yaspo, Peter Priestley, Ewart Kuijk, Edwin Cuppen, Arne Van Hoeck
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/367df1c239a3400ab814acaa85f4ccbc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:367df1c239a3400ab814acaa85f4ccbc
record_format dspace
spelling oai:doaj.org-article:367df1c239a3400ab814acaa85f4ccbc2021-12-02T15:35:57Z5-Fluorouracil treatment induces characteristic T>G mutations in human cancer10.1038/s41467-019-12594-82041-1723https://doaj.org/article/367df1c239a3400ab814acaa85f4ccbc2019-10-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-12594-8https://doaj.org/toc/2041-17235-Fluorouracil (5-FU) is a commonly used chemo drug to treat cancer patients. Using in vitro 5-FU treated organoids and in vivo 5-FU treated human cancer data, the authors describe a 5-FU mutational signature that is similar to COSMIC signature 17 frequently observed in untreated cancersSharon ChristensenBastiaan Van der RoestNicolle BesselinkRoel JanssenSander BoymansJohn W. M. MartensMarie-Laure YaspoPeter PriestleyEwart KuijkEdwin CuppenArne Van HoeckNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-11 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Sharon Christensen
Bastiaan Van der Roest
Nicolle Besselink
Roel Janssen
Sander Boymans
John W. M. Martens
Marie-Laure Yaspo
Peter Priestley
Ewart Kuijk
Edwin Cuppen
Arne Van Hoeck
5-Fluorouracil treatment induces characteristic T>G mutations in human cancer
description 5-Fluorouracil (5-FU) is a commonly used chemo drug to treat cancer patients. Using in vitro 5-FU treated organoids and in vivo 5-FU treated human cancer data, the authors describe a 5-FU mutational signature that is similar to COSMIC signature 17 frequently observed in untreated cancers
format article
author Sharon Christensen
Bastiaan Van der Roest
Nicolle Besselink
Roel Janssen
Sander Boymans
John W. M. Martens
Marie-Laure Yaspo
Peter Priestley
Ewart Kuijk
Edwin Cuppen
Arne Van Hoeck
author_facet Sharon Christensen
Bastiaan Van der Roest
Nicolle Besselink
Roel Janssen
Sander Boymans
John W. M. Martens
Marie-Laure Yaspo
Peter Priestley
Ewart Kuijk
Edwin Cuppen
Arne Van Hoeck
author_sort Sharon Christensen
title 5-Fluorouracil treatment induces characteristic T>G mutations in human cancer
title_short 5-Fluorouracil treatment induces characteristic T>G mutations in human cancer
title_full 5-Fluorouracil treatment induces characteristic T>G mutations in human cancer
title_fullStr 5-Fluorouracil treatment induces characteristic T>G mutations in human cancer
title_full_unstemmed 5-Fluorouracil treatment induces characteristic T>G mutations in human cancer
title_sort 5-fluorouracil treatment induces characteristic t>g mutations in human cancer
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/367df1c239a3400ab814acaa85f4ccbc
work_keys_str_mv AT sharonchristensen 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer
AT bastiaanvanderroest 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer
AT nicollebesselink 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer
AT roeljanssen 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer
AT sanderboymans 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer
AT johnwmmartens 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer
AT marielaureyaspo 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer
AT peterpriestley 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer
AT ewartkuijk 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer
AT edwincuppen 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer
AT arnevanhoeck 5fluorouraciltreatmentinducescharacteristictgmutationsinhumancancer
_version_ 1718386404225974272